Selux’s interdisciplinary team of expertise in microbiology, biochemistry, chemistry, engineering, software, and algorithm design is buttressed by distinguished experts in Clinical Microbiology, Infectious Disease, and Machine Learning. We take our work seriously because it’s personal to each and every one of us.
Experts predict that without a major change, deaths from superbugs will surpass deaths from cancer by 2050. This problem can be solved with rapid AST to inform personalized treatment decisions. Selux is closing the gap between ID and susceptibility testing to bolster antibiotic stewardship.
If you want to join a passionate group of nerds who take pleasure in doing our part to outsmart bacteria, take a look at our open positions and tell us which piece if the puzzle you can tackle.